Citigroup’s Globus Medical GMED Stock Holding History

Citigroup’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-75,000	Closed	-$2.23M	–	7585
2017 Q3	$2.23M	Buy	+75,000	New	+$2.29M	﹤0.01%	2542

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Citigroup's GMED Position: Q2 2026 in Review

Citigroup increased its Globus Medical (GMED) stake by 7% in Q2 2026, buying an estimated $181K and bringing the position to 32,700 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2735.

Citigroup first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.61M in Q1 2021. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Citigroup held 32,700 shares of Globus Medical worth $2.58M as of Q2 2026.
Citigroup bought 2,127 Globus Medical shares in Q2 2026, an estimated $181K.
Globus Medical made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2735 holding.
Citigroup first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
Citigroup's Globus Medical position peaked at $7.61M in Q1 2021.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.